EMP2 is a novel therapeutic target for endometrial cancer stem cells

Previous studies have suggested that overexpression of the oncogenic protein epithelial membrane protein-2 (EMP2) correlates with endometrial carcinoma progression and ultimately poor survival from disease. To understand the role of EMP2 in the etiology of disease, gene analysis was performed to sho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Kiyohara, Meagan H., Dillard, Christen, Tsui, Jessica, Kim, Sara Ruth, Lu, Jianyi, Sachdev, Divya, Goodglick, Lee, Tong, Maomeng, Torous, Vanda Farahmand, Aryasomayajula, Chinmayi, Wang, Wei, Najafzadeh, Parisa, Gordon, Lynn K., Braun, Jonathan, McDermott, Sean, Wicha, Max S., Wadehra, Madhuri
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648618/
https://ncbi.nlm.nih.gov/pubmed/28604744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados